BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19664662)

  • 21. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.
    Lackman-Smith C; Osterling C; Luckenbaugh K; Mankowski M; Snyder B; Lewis G; Paull J; Profy A; Ptak RG; Buckheit RW; Watson KM; Cummins JE; Sanders-Beer BE
    Antimicrob Agents Chemother; 2008 May; 52(5):1768-81. PubMed ID: 18316528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles.
    DeMarco SJ; Henze H; Lederer A; Moehle K; Mukherjee R; Romagnoli B; Robinson JA; Brianza F; Gombert FO; Lociuro S; Ludin C; Vrijbloed JW; Zumbrunn J; Obrecht JP; Obrecht D; Brondani V; Hamy F; Klimkait T
    Bioorg Med Chem; 2006 Dec; 14(24):8396-404. PubMed ID: 17010618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs.
    Vermeire K; Schols D
    J Antimicrob Chemother; 2005 Aug; 56(2):270-2. PubMed ID: 15980096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
    Miller JF; Turner EM; Gudmundsson KS; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2125-8. PubMed ID: 20207537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer.
    Teleshova N; Chang T; Profy A; Klotman ME
    Antimicrob Agents Chemother; 2008 May; 52(5):1751-8. PubMed ID: 18332174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K; Tanaka R; Ogura T; Ito M; Kumakura S; Yanaka M; Nishizawa M; Sugiura W; Yamamoto N; Tanaka Y
    J Infect Dis; 2008 Jan; 197(1):134-41. PubMed ID: 18171296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity.
    Manetti F; Tintori C; Armand-Ugón M; Clotet-Codina I; Massa S; Ragno R; Esté JA; Botta M
    J Chem Inf Model; 2006; 46(3):1344-51. PubMed ID: 16711753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.
    Neurath AR; Strick N; Li YY; Debnath AK
    Ann N Y Acad Sci; 2005 Nov; 1056():311-27. PubMed ID: 16387698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
    Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
    J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry.
    Liu DY; Ye JT; Yang WH; Yan J; Zeng CH; Zeng S
    Biomed Environ Sci; 2004 Jun; 17(2):153-64. PubMed ID: 15386941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.
    Saïdi H; Magri G; Carbonneil C; Bouhlal H; Hocini H; Belec L
    AIDS Res Hum Retroviruses; 2009 May; 25(5):497-509. PubMed ID: 19397398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications.
    Férir G; Petrova MI; Andrei G; Huskens D; Hoorelbeke B; Snoeck R; Vanderleyden J; Balzarini J; Bartoschek S; Brönstrup M; Süssmuth RD; Schols D
    PLoS One; 2013; 8(5):e64010. PubMed ID: 23724015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.
    Pirrone V; Wigdahl B; Krebs FC
    Antiviral Res; 2011 Jun; 90(3):168-82. PubMed ID: 21439325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
    Wu Z; Cocchi F; Gentles D; Ericksen B; Lubkowski J; Devico A; Lehrer RI; Lu W
    FEBS Lett; 2005 Jan; 579(1):162-6. PubMed ID: 15620707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
    AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms.
    Cassol E; Cassetta L; Rizzi C; Alfano M; Poli G
    J Immunol; 2009 May; 182(10):6237-46. PubMed ID: 19414777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.
    Thoma G; Streiff MB; Kovarik J; Glickman F; Wagner T; Beerli C; Zerwes HG
    J Med Chem; 2008 Dec; 51(24):7915-20. PubMed ID: 19053768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
    Liu KK; Dorovini-Zis K
    J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.